Android app on Google Play

Abbott (ABT) Completes Separation of AbbVie (ABBV)

January 2, 2013 7:57 AM EST Send to a Friend
Abbott (NYSE: ABT) completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. AbbVie will begin trading independently on the New York Stock Exchange today under the symbol "ABBV" (NYSE: ABBV).

On Nov. 28, 2012, Abbott's board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. For every 1 share of Abbott common shares held as of close of business on Dec. 12, 2012, Abbott shareholders received 1 share of AbbVie common stock on Jan. 1, 2013.




You May Also Be Interested In


Related Categories

Corporate News, Hot Corp. News

Related Entities

Dividend

Add Your Comment